Stockholder's Equity (Deficit) - Redeemable Series A Convertible Preferred Stock (Details) (Imported) - USD ($)								12 Months Ended
	Oct. 26, 2022	Sep. 30, 2022	Aug. 04, 2022	Aug. 03, 2022	Jul. 27, 2022	Nov. 02, 2021	May 18, 2020	Dec. 31, 2022	Dec. 31, 2021	May 18, 2022
Class of Stock [Line Items]
Cumulative dividends percentage									8.00%
Non-cash interest expense								$ 108,591	$ 15,551
Number of common shares to issue on exercise of warrants								108,650
Warrants exercise price (in dollars per share)			$ 6.00
Percentage of cashless warrants exercised	20.00%			20.00%
Issuance of common stock and warrants, net of issuance costs (in shares)	36,166		931,667	36,196		426,500
Granted								108,650
Weighted Average Remaining Contractual Term (Years) rollforward
Aggregate Intrinsic Value						$ 8,100,000
Series A preferred stock
Class of Stock [Line Items]
Preferred stock designated							2,500
Cumulative dividends percentage							8.00%
Minimum conversion price							$ 1,000
Per share of final price							$ 902.70			$ 902.70
Non-cash interest expense								$ 108,591	15,551
Accrued preferred dividends									129,992
Non-cash dividends									$ 108,858
Closing price							$ 902.70			$ 902.70
Prefunded warrants
Class of Stock [Line Items]
Number of common shares to issue on exercise of warrants			401,667			42,250
Warrants exercise price (in dollars per share)			$ 0.005		$ 0.005	$ 31.95
Granted			401,667			42,250
TardiMed
Class of Stock [Line Items]
Number of common shares on conversion of units								62,181	108,750
Number of common shares to issue on exercise of warrants								181,083
Outstanding, beginning of period
Granted								181,083
Exercised								(72,433)
Outstanding and exercisable, end of period								108,650
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price								$ 0.005
Weighted Average Price, Issued								0.005
Weighted Average Price, Exercised								$ 0.005
Weighted Average Remaining Contractual Term (Years) rollforward
Aggregate Intrinsic Value								$ 189,595
TardiMed | Series A preferred stock
Class of Stock [Line Items]
Number of common shares on conversion of units					1,819
TardiMed | Redeemable Series A Convertible Preferred Stock
Class of Stock [Line Items]
Number of common shares on conversion of units					1,819
TardiMed | Prefunded warrants
Class of Stock [Line Items]
Per share of final price					$ 11.95
Number of common shares to issue on exercise of warrants					181,083
Closing price					$ 11.95
Percent of warrant becomes exercisable		20.00%			20.00%
Warrants exercise price (in dollars per share)					$ 0.0001
Granted					181,083